Could a Different Kind of Blood Test Improve Ovarian Cancer Screening?
A study found that a blood test measuring cancer-associated proteins detected signs of early-stage ovarian cancer in samples collected up to a year before diagnosis.
Tag: biomarkers
All
Latest
All
Latest
New Liquid Biopsy Approach Reveals Liver Cancer Biomarkers Missed by Conventional Methods
A peer-reviewed study found that the platform identified 57% more proteins than bulk methods and differentiated hepatocellular carcinoma from cirrhosis in plasma samples.
All
Latest
Renew Biotechnologies, Mayo Clinic Partner to Evaluate cfDNA Biomarker in Multiple Sclerosis
Renew Biotechnologies and Mayo Clinic have partnered to evaluate NeuroLens, a cfDNA-based test, for monitoring central nervous system injury and disease progression in multiple sclerosis and related neuroimmunologic conditions.
AMH Fertility Testing Rose 13-Fold Despite Inability to Predict Natural Conception, Study Finds
General practitioner requests for AMH fertility tests rose more than 13-fold from 2011 to 2021, despite research showing these tests cannot predict natural conception, according to a Flinders University study of 1.4 million health records.
Read More
5Q Spectra to Debut Blood Test for Prostate Cancer Detection
5Q Spectra plans to launch the Prostate Dx blood test, designed to help assess prostate cancer risk after elevated PSA results and potentially reduce unnecessary biopsies.
Read More
Labcorp Acquires MLM Medical Labs to Expand Clinical Trial Laboratory Network
Labcorp has acquired MLM Medical Labs, expanding its central laboratory network to four continents and strengthening biomarker and specialty testing capabilities for clinical trials, according to a company announcement.
Read More
AI Analysis of H&E Slides Reveals Genomic and Immune Patterns in Lung Cancer
AI models analyzing routine H&E slides can identify genomic alterations and immune patterns in NSCLC, supporting biomarker discovery and patient stratification, according to studies to be presented by Lunit at WCLC 2026.
Read More
Cell-Free DNA Analysis Distinguishes Recurrent From Primary Breast Cancer
Kumamoto University researchers have developed a blood test that analyzes nucleosome structures in cell-free DNA to detect breast cancer recurrence.
Read More
Clinical Study Validates H3.1 Nucleosomes as Sepsis Biomarker
A study validates Nu.Q NETs H3.1 nucleosomes as independent predictors of 28-day mortality and renal replacement therapy need in sepsis and septic shock, according to VolitionRx.
Read More
Humanity and Quest Diagnostics Launch Biological Age Analysis in the US
Humanity Health and Quest Diagnostics have launched a biological age analysis add-on for select health profile tests in the US, allowing users to assess aging biomarkers using routine blood samples.
Read More
Urine Biomarker Test Improves Prediction of Donor Kidney Outcomes
A Johns Hopkins study reports that adding three urine biomarkers to standard assessments raises the accuracy of predicting deceased donor kidney transplant success from 80% to 86%.
Read More
FDA Clears First Single-Biomarker Alzheimer Blood Test for Rule-In and Rule-Out Assessment
The FDA has cleared Roche’s Elecsys pTau217 blood test to aid in identifying Alzheimer disease amyloid pathology, marking the first single-biomarker assay for both rule-in and rule-out use on existing lab instruments.
Read More
FDA Clears Alzheimer’s Blood Test for Adults as Young as 40
The FDA has cleared the first blood-based Alzheimer’s test authorized for symptomatic adults as young as 40.
Read More
Amsbio Introduces Synthetic Cell Mimics for Flow Cytometry
Amsbio has launched synthetic cell mimic controls for flow cytometry, aiming to improve lot-to-lot consistency and reproducibility in diagnostics and cell therapy manufacturing.
Read More
Low-cost Blood Test on a Chip Diagnoses Lung Cancer Without DNA Sequencing
Tel Aviv University researchers have developed a low-cost blood test that detects lung cancer by analyzing optical DNA fingerprints, achieving 93.1% sensitivity and 90.3% specificity.
Read More
Liquid Biopsy Platform Uses Machine Learning to Prioritize Lymphoma Diagnosis
Researchers at MUSC Hollings Cancer Center have developed the ADLiB liquid biopsy platform, which uses machine learning to prioritize lymphoma diagnosis, identifying high-risk patients with up to 95% accuracy.
Read More
Study Details New ctDNA Isolation Method for Liquid Biopsy
VolitionRx has published peer-reviewed data on its Capture-Seq technology, reporting over 99% pure ctDNA isolation from plasma and 95% detection of early-stage cancers in validation cohorts.
Read More
Caris Life Sciences Launches PTEN IHC Testing for Prostate Cancer
Caris Life Sciences has launched in-house PTEN IHC testing to identify prostate cancer patients eligible for FDA-approved, biomarker-guided therapy, supporting precision treatment for PTEN-deficient mAPMN/S prostate cancer.
Read More